Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
The U.S. Food and Drug Administration has approved three drugs for human use that contain active ingredients present in or similar to those in marijuana.
Marinol, Sydros, and Cesamet, and Zynerba Pharmaceuticals’ ZYN002 Gel should be delivering Phase II study results late this summer.
Phase I results for using ZYN002 Gel for patients with Fragile X Syndrome (FXS) are expected this summer.
Top-line Phase II results for studies involving using the gel on adult epilepsy and osteoarthritis in knees are projected to be ready in July or August 2017.
Synthetic cannabinoids are currently categorized as Schedule 1 substances because of their relationship with marijuana, but once they gain approval by the U.S. Food and Drug Administration (FDA), they will have a demonstrated medical benefit and will likely be re-categorized to a Schedule 3 or 4, or possibly de-scheduled entirely, according to Zynerba Pharmaceuticals CEO Armando Anido.
Right now there is no known cure for Fluoroquinolone Toxicity Syndrome, also known as Floxing.
However, medical marijuana high in THC has been shown help with pain, help repair damaged cells, and assist with sleep.
All of these happen to be essential for healing.
Stated legal cannabis sales in the U.S. in 2016 reached $6.7 billion.
The number was reported in a January 3, 2017, Archview Group press release.
This was a growth of 30 percent over the previous year.
Sales are projected to increase to $20.2 billion by the year 2021, representing a 25 percent compound annual growth rate.
Archview Market Research Editor-in-Chief, Tom Adams, stated:
“The biggest game changer for the future are the four new states that approved adult-use measures; 21 percent of the total US population now live in legal adult-use markets.”
He further stated that:
“Spending in the largest three adult-use markets (CO, WA, and OR) was up 62 percent through September after doubling in 2015. This was fueled in large part by the sudden popularity of alternative ingestion methods such as edibles and concentrates.”
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
Consumers are advised that Melissa’s brand fresh organic basil in 2.0-ounce and 4.0-ounce packages are now included in a April 19, 2024 recall initiated by Miami, Florida-based Infinite Herbs LLC. The Melissa’s brand portion of the recall covers 96 2.0-ounce packages of fresh organic basil
Fresenius Kabi USA, LLC has announced a corrective Class I recall of an infusion pump software, LVP Software, that runs on the Ivenix Infusion System (IIS). Initiated by the firm on March 7, 2024, the action comes after multiple software anomalies were identified and found
According to the FDA, 20-ounce packages of “King Kullen Broccoli Cutlets with Bread Crumbs and Parmesan” have been recalled by New Haven, Connecticut-based Gracie’s Kitchen due to the potential presence of undeclared sesame and wheat. Individuals who live with allergies to either allergen are advised